Old Web
English
Sign In
Acemap
>
authorDetail
>
Sheila Hoff
Sheila Hoff
University of California, San Diego
Medicine
Ibrutinib
Internal medicine
Physical therapy
Oncology
4
Papers
41
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib
2018
Cancer
Max J. Gordon
Michael Churnetski
Hamood Alqahtani
Xavier Rivera
Adam S. Kittai
Stephen M. Amrock
Spencer L. James
Sheila Hoff
Sudhir Manda
Stephen E. Spurgeon
Michael Y. Choi
Jonathon B. Cohen
Daniel O. Persky
Alexey V. Danilov
Show All
Source
Cite
Save
Citations (38)
Effect of concurrent CYP3A4 interacting medications on ibrutinib outcomes in patients with CLL.
2018
Journal of Clinical Oncology
Adam S. Kittai
Ashray Maniar
Max J. Gordon
Michael Churnetski
Xavier Rivera
Hamood Alqahtani
Sheila Hoff
Douglas Z. Rice
Gregory Rice
Daniel O. Persky
Michael Y. Choi
Jonathon B. Cohen
Alexey V. Danilov
Show All
Source
Cite
Save
Citations (1)
Impact of Individual Comorbidities on Treatment Outcomes in Chronic Lymphocytic Leukemia
2018
Blood
Max J. Gordon
Michael C Churnetski
Hamood Alqahtani
Xavier Rivera
Adam Kittai
Nur Bruss
Sheila Hoff
Michael Y. Choi
Jonathon B. Cohen
Daniel O. Persky
Byung Park
Alexey V. Danilov
Show All
Source
Cite
Save
Citations (0)
Lenalidomide and Rituximab For The Treatment Of Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results Of Planned Interim Analysis
2013
Blood
Januario E. Castro
Sheila Hoff
Hongying Li
Laura Z. Rassenti
Danelle F. James
Karen Messer
Thomas J. Kipps
Show All
Source
Cite
Save
Citations (2)
1